glp-1 drug exposure pharmaceutical companies 2025 Pharma Giants Bet on Next-Generation Treatments to Sustain Growth GLP-1 Market Size to Hit

A 2021 In another recent meta-analysis, researchers found that individuals with ulcerative colitis (UC) who took curcumin and mesalamine, a drug used to treat UC, were almost three times more likely to achieve remission than those who took mesalamine alone

This is not theoretical speculation

Labile plasma iron (LPI) as an indicator of chelatable plasma redox activity in iron-overloaded -thalassemia/HbE patients treated with an oral chelator [J]

Several clinical trials are currently investigating whether GLP-1 receptor agonists can slow cognitive decline or reduce Alzheimer's disease risk

Zhang, R., Xu, L., and Dong, C., Protein Peptide Lett